Don’t Trade Away Health: Brief to Canada’s Minister of International Trade Regarding the Trans‐Pacific Partnership Negotiations and Access to Medicines

Billions of people around the world lack access to life‐saving medicines. While this is because of a number of synergistic causes, one critical factor is the prohibitively high cost of patent‐monopolized medications. Provisions currently being negotiated for the Trans‐Pacific Partnership agreement (TPP) risk exacerbating this situation, which for many is a matter of life and death.